Company Badge
USPTO Data Jan 1 1976 - Oct 13 2026
5 Patents
#66 in La Jolla, CA
#12,070 in California
#51,540 in US
Anaphore, Inc.
Forward Citations = 28
13 inventors:
La Jolla, CA, United States of America
Anaphore, Inc.
% Expired Patents = 100.0
EPO Patents = 2
Forward Citations = 28
Loading Chart...
Loading Chart...
13 inventors (with patents filed for the assignee):
Thor Las Holtet (5 out of 12 patents)
Michael Etzerodt (4 out of 6 patents)
Niels Jonas Heilskov Graversen (4 out of 4 patents)
4. Hans Christian Thøgersen (3 out of 3 patents)
5. Jette Sandholm Kastrup (3 out of 3 patents)
6. Bettina Bryde Nielsen (3 out of 3 patents)
7. Ingrid Kjøller Larsen (2 out of 2 patents)
8. Helle Krogh Ottow (1 out of 1 patent)
9. Mette Munch (1 out of 1 patent)
10. Mikkel Holmen Andersen (1 out of 1 patent)
11. Josephus Dirk Nieland (1 out of 2 patents)
12. Hans Christian Thogersen (1 out of 1 patent)
13. Ingrid Kjoller Larsen (1 out of 1 patent)
5 patents:
Company Overview
Anaphore, Inc. is a biotechnology company focused on developing novel protein therapeutics for the treatment of autoimmune diseases and cancer. Their proprietary technology platform allows for the design and engineering of highly specific and potent biologics to target disease pathways. With a strong pipeline of candidates in preclinical and clinical development, Anaphore, Inc. is dedicated to improving patient outcomes and advancing the field of biologic therapeutics.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Anaphore, Inc.. Retrieved from https://idiyas.com/company/anaphore
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
2 patents (EPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]